Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms.

ABSTRACT: GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms.

PROVIDER: PRJNA832809 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18959200_1.fastq.gz	Fastqsanger.gz
	SRR18959200_2.fastq.gz	Fastqsanger.gz
	SRR18959201_1.fastq.gz	Fastqsanger.gz
	SRR18959201_2.fastq.gz	Fastqsanger.gz
	SRR18959202_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 100

Similar Datasets

GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms [ChIP-seq]

Project description:In order to identify GATA-3 target genes in T-cell lymphoproliferative neoplasms, we performed GATA-3 ChIP-seq on 3 cutaneous T-cell lymphoma (CTCL) and 4 T-cell acute lymphoblastic leukemia (T-ALL). We have also established cell lines in which GATA-3 was knocked down by shRNA.

2022-04-30 | GSE201743 | GEO

GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms [RNA-seq]

2022-04-30 | GSE201742 | GEO

GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms [ChIP-seq]

Project description:GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms [ChIP-seq]

| PRJNA832810 | ENA

GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms [RNA-seq]

Project description:GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms [RNA-seq]

| PRJNA832811 | ENA

GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms.

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-04-30 | GSE201744 | GEO

A Drosophila proto-oncogene homolog controls aggression via aminergic neurons

Project description:A Drosophila proto-oncogene homolog controls aggression via aminergic neurons

| PRJNA625242 | ENA

The proto-oncogene TCL1A deregulates mitotic checkpoint transition and genomic stability in CLL

Project description:Upregulation of the proto-oncogene TCL1A is causally implicated in various B- and T-cell malignancies. High-level TCL1A correlates with aggressive disease features and inferior clinical outcomes. However, molecular and cell-biological consequences of TCL1A dysregulation are not fully elucidated. Here, we identify CDC20 and other molecules of the safeguarding cell cycle checkpoints as novel TCL1A-interactors. In different model systems of B-cell leukemia/lymphoma, TCL1A overexpression accelerated cell cycle transition, impaired apoptotic damage responses in association with pronounced chromosome mis-segregation and caused cellular aneuploidy. In primary CLL samples, low CDC20 expression correlated with high expression of TCL1A and more aggressive disease characteristics. In line, a low CDC20 expression was a marker for reduced progression-free survival in CLL patients. Finally, knockdown of CDC20 in TCL1A-initiated murine lymphomas promoted chromosome disbalances and leukemia outgrowth. Overall, we discovered a cell-cycle associated effect of TCL1A by interfering with a proficient cell cycle transition. This adds to our concept of TCL1A’s transforming impact by targeting genome stability.

2022-11-14 | PXD030773 | Pride

The proto-oncogene TCL1A deregulates mitotic checkpoint transition and genomic stability in CLL

2022-11-14 | PXD030776 | Pride

Activation of proto-oncogenes by disruption of chromosome neighborhoods [chIA-PET]

Project description:Mutations such as gene fusion, translocation and focal amplification are a frequent cause of proto-oncogene activation during tumorigenesis, but such mutations do not explain all cases of proto-oncogene activation. Here we show that disruption of local chromosome conformation can also activate proto-oncogenes in human cells. We mapped chromosome structures in T-cell acute lymphoblastic leukemia (T-ALL), and found that active oncogenes and silent proto-oncogenes generally occur within insulated neighborhoods formed by the looping of two interacting CTCF sites co-occupied by cohesin. Recurrent microdeletions frequently overlap neighborhood boundary sites in T-ALL genomes, and we demonstrate that site-specific perturbation of loop boundaries is sufficient to activate the respective proto-oncogenes in non-malignant cells. We found somatic genomic rearrangements affecting loop boundaries in many cancers. These results suggest that chromosome structural organization is fundamental to identify functional somatic alterations in cancer genomes.

2015-05-28 | GSE68977 | GEO

Activation of proto-oncogenes by disruption of chromosome neighborhoods [ChIP-Seq]

2015-05-28 | GSE68976 | GEO